CSA Medical, Inc

Form 483 issued March 23, 2026 · Lexington, Massachusetts

Inspection
Mar 17 – Mar 23, 2026
Observations
1
Pages
3
FEI number
3010140265

In short: On March 23, 2026, FDA issued a Form 483 with 1 observation to CSA Medical, Inc in Lexington, Massachusetts (FEI 3010140265) after an inspection that ran Mar 17 – Mar 23, 2026. The investigators were Nabil Nakhoul and Thomas Siebertz. Most observations concern cAPA; the most-cited regulation is 21 CFR 820.90 (nonconforming product).

At a glance

1 of 1 observations on this 483 concern capa.

CAPA1

Most cited: 21 CFR 820.90 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Procedures to define the controls and related responsibilities and authorities for the identification, documentation, segregation, evaluation…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at CSA Medical, Inc?

FDA listed 1 observation on this Form 483, mostly about cAPA. The most-cited regulation is 21 CFR 820.90 (nonconforming product). The opening words of each observation are shown on this page.

Who inspected CSA Medical, Inc?

Nabil Nakhoul and Thomas Siebertz are named on this Form 483, for the inspection of Mar 17 – Mar 23, 2026. Each investigator has a profile showing what they cite most.

When was CSA Medical, Inc inspected by FDA?

The inspection ran Mar 17 – Mar 23, 2026, and the Form 483 is dated March 23, 2026.

How do I get the full Form 483 for CSA Medical, Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free